Literature DB >> 3029305

Cytomegalovirus in urine specimens has host beta 2 microglobulin bound to the viral envelope: a mechanism of evading the host immune response?

J A McKeating, P D Griffiths, J E Grundy.   

Abstract

We have previously reported that human cytomegalovirus (CMV) from urine specimens cannot be captured onto a solid phase by CMV-specific monoclonal antibodies that can capture CMV grown in vitro. We report here that CMV exists in vivo in body fluids such as urine as beta 2 microglobulin (beta 2 m)-coated particles. We have demonstrated the presence of beta 2m on CMV purified directly from urine by Western blotting and have shown that the beta 2m was associated with the viral envelope. Urinary CMV could be specifically bound by an affinity column comprising a monoclonal antibody specific for beta 2m bound to Sepharose. The beta 2m-coated urinary CMV could not be neutralized by hyperimmune globulin, human immune sera or murine monoclonal antibodies that could neutralize CMV grown in cell culture. We conclude that the binding of beta 2m by CMV masks the important antigenic sites necessary for neutralization which are recognized by man's immune response. We propose that CMV has evolved this mechanism of coating itself in a host protein as a mechanism of evading the host immune response and facilitating transmission between individuals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029305     DOI: 10.1099/0022-1317-68-3-785

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Detection of cytomegalovirus in urine samples by an enzyme-linked immunosorbent assay using a monoclonal antibody against the viral 150-kilodalton protein.

Authors:  T Yamanaka; K Kiyotani; T Sakaguchi; Y Fukuda; K Dohi; M Yamada; M Yoshida; S Nii; T Yoshida
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.

Authors:  Xiaohong Cui; Stuart P Adler; Mark R Schleiss; Ravit Arav-Boger; Gail J Demmler Harrison; Michael A McVoy
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

Review 3.  Molecular biology of cytomegalovirus.

Authors:  V C Emery; P D Griffiths
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

4.  Proteins associated with purified human cytomegalovirus particles.

Authors:  C J Baldick; T Shenk
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 5.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

Review 6.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 7.  Cytomegalovirus infection in the gastrointestinal tract.

Authors:  R Chetty; D E Roskell
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

8.  Double fluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by flow cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells.

Authors:  M Steinmassl; K Hamprecht
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted.

Authors:  H Browne; M Churcher; T Minson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Low-dose human cytomegalovirus infection of human fibroblast cultures induces lymphokine-activated killer cell resistance: interferon-beta-mediated target cell protection does not correlate with up-regulation of HLA class I surface molecules.

Authors:  K Hamprecht; M Steinmassl
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.